References
- Cunningham F G, Gant N F, Leveno K J, Gilstrap L C, III, Hauth J C, Wenstrom K D. Diseases and abnormalities of the placenta. Williams Obstetrics21th ed. McGraw-Hill, USA 2001; 835–839
- Lawler S D, Fisher R A, Dent J. A prospective genetic study of complete and partial hydatidiform moles. Am J Obstet Gynecol 1991; 164: 1270–1277
- Wolf N G, Lage J M. Genetic analysis of gestational trophoblastic disease: a review. Semin Oncol 1995; 22: 113–120
- Semer D A, Macfee M S. Gestational trophoblastic disease: epidemiology. Semin Oncol 1995; 22: 109–112
- Wade R V. Clomiphene-citrate induced hydatidiform mole. South Med J 1980; 73: 1417–1418
- Bates M, Everard J, Wall L, Horsman J M, Hancock B W. Is there a relationship between treatment for infertility and gestational trophoblastic disease?. Hum Reprod 2004; 19: 365–367
- Mor-Joseph S, Anteby S O, Granat M, Brzezinsky A, Evron S. Recurrent molar pregnancies associated with clomiphene citrate and human gonadotrophins. Am J Obstet Gynecol 1985; 151: 1085–1086
- Shoham Z, Zosmer A, Insler V. Early miscarriage and fetal malformations after inducing of ovulation (by clomiphen citrate and/or human menotropins), in vitro fertilization and gamete intrafallopian transfer. Fertil Steril 1991; 55: 1–11
- Venn A, Lumley J. Clomiphene citrate and pregnancy outcome. Aust N Z J Obstet Gynecol 1994; 34: 56
- Kousta E, White D M, Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update 1997; 3: 359–365